Sigumir – Bone & Cartilage Bioregulator
Sigumir is a dual-action bioregulator peptide targeting both osseous and cartilaginous tissue. It supports osteoblast-mediated bone formation while simultaneously maintaining the proteoglycan structure of articular cartilage for pain-free, flexible joints.
Description
Sigumir is a precision-engineered bioregulator peptide that selectively targets bone and cartilage through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within bone and cartilage cells, Sigumir helps normalise osteoblast activity and articular cartilage maintenance—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for musculoskeletal tissue maintenance, making it a fundamentally different approach from conventional supplementation.